presents

Thailand presents ‘The New Thailand’ vision at ITB Berlin 2026

Healing-led luxury, sustainable routes and hidden gems advance Thailand's world-class positioning in Europe under TAT's 'Unforgettable Experience: Healing is the…

7 hours ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease…

2 weeks ago

CGTN AMERICA & CCTV UN: CMG Presents “Prelude to the Spring Festival Gala” in New York City, Celebrating the Year of the Horse

WASHINGTON, Feb. 12, 2026 /PRNewswire/ -- CGTN America & CCTV UN releases CMG Presents "Prelude to the Spring Festival Gala"…

3 weeks ago

HABANOS, S.A. PRESENTS TRINIDAD CORCEL: AN EXCLUSIVE VITOLA TO CELEBRATE THE CHINESE NEW YEAR

Habanos, S.A. presents Trinidad Corcel, the latest addition to the Trinidad brand's distinguished portfolio of vitolas.Presented in the Patricios factory…

1 month ago

Castrol proudly presents: Drive Me To The Moon

Castrol unveils a new documentary in collaboration with Lunar Outpost: a worldwide premiere at Space Center Houston LONDON, Jan. 15,…

2 months ago

ASUS Republic of Gamers Presents Next-Gen Gaming Innovations, Commemorates 20 Years of Gaming Excellence at CES 2026

KEY POINTS Two decades of gaming leadership: At its Dare to Innovate virtual event, ROG celebrates 20 years of fearless…

2 months ago

Samsung Presents ‘Your Companion to AI Living’ at The First Look during CES 2026

Next-generation AI-powered devices and experiences to be showcased at the company's exclusive exhibition through January 7LAS VEGAS, Jan. 5, 2026…

2 months ago

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…

3 months ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…

3 months ago